Teva Pharmaceutical (Israel) Price History

TEVA Stock  ILA 7,798  171.00  2.15%   
If you're considering investing in Teva Stock, it is important to understand the factors that can impact its price. As of today, the current price of Teva Pharmaceutical stands at 7,798, as last reported on the 22nd of January, with the highest price reaching 7,979 and the lowest price hitting 7,798 during the day. Teva Pharmaceutical appears to be very steady, given 3 months investment horizon. Teva Pharmaceutical owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.0935, which indicates the firm had a 0.0935 % return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Teva Pharmaceutical Industries, which you can use to evaluate the volatility of the company. Please review Teva Pharmaceutical's Risk Adjusted Performance of 0.0855, coefficient of variation of 1079.11, and Semi Deviation of 1.86 to confirm if our risk estimates are consistent with your expectations.
  
Teva Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = 0.0935

Best PortfolioBest Equity
Good Returns
Average Returns
Small ReturnsTEVA
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative Returns

Estimated Market Risk

 3.59
  actual daily
31
69% of assets are more volatile

Expected Return

 0.34
  actual daily
6
94% of assets have higher returns

Risk-Adjusted Return

 0.09
  actual daily
7
93% of assets perform better
Based on monthly moving average Teva Pharmaceutical is performing at about 7% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Teva Pharmaceutical by adding it to a well-diversified portfolio.

Teva Pharmaceutical Stock Price History Chart

There are several ways to analyze Teva Stock price data. The simplest method is using a basic Teva candlestick price chart, which shows Teva Pharmaceutical price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest PriceDecember 26, 20248222.0
Lowest PriceDecember 16, 20245954.0

Teva Pharmaceutical January 22, 2025 Stock Price Synopsis

Various analyses of Teva Pharmaceutical's daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Teva Stock. It can be used to describe the percentage change in the price of Teva Pharmaceutical from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Teva Stock.
Teva Pharmaceutical Price Action Indicator(176.00)
Teva Pharmaceutical Accumulation Distribution 15,207 
Teva Pharmaceutical Price Daily Balance Of Power(0.94)
Teva Pharmaceutical Market Facilitation Index 0.0003 
Teva Pharmaceutical Price Rate Of Daily Change 0.98 

Teva Pharmaceutical January 22, 2025 Stock Price Analysis

When benchmark price declines in a down market, there may be an uptick in Teva Stock price where buyers come in believing the asset is cheap or selling overdone. The opposite is true when the market is bullish. You can use Teva Pharmaceutical intraday prices and daily technical indicators to check the level of noise trading in Teva Stock and then apply it to test your longer-term investment strategies against Teva.

Teva Stock Price History Data

The price series of Teva Pharmaceutical for the period between Thu, Oct 24, 2024 and Wed, Jan 22, 2025 has a statistical range of 2268.0 with a coefficient of variation of 10.03. The price distribution for the period has arithmetic mean of 6896.09. The median price for the last 90 days is 6673.0. The company completed stock split (2:1) on 27th of June 2004. Teva Pharmaceutical had dividends distributed to its stock-holders on 2017-11-28.
OpenHighLowCloseVolume
01/21/2025 7,969  7,979  7,798  7,798  670,390 
01/20/2025 7,970  7,970  7,925  7,969  284,754 
01/16/2025 7,894  7,949  7,800  7,842  1,012,111 
01/15/2025 7,627  7,830  7,600  7,793  826,086 
01/14/2025 7,450  7,559  7,424  7,530  1,275,956 
01/13/2025 7,858  7,869  7,579  7,579  1,063,526 
01/09/2025 7,923  7,940  7,845  7,870  562,782 
01/08/2025 7,873  7,930  7,842  7,917  1,420,394 
01/07/2025 7,704  7,873  7,704  7,873  1,389,910 
01/06/2025 7,820  7,864  7,704  7,704  1,030,061 
01/02/2025 8,008  8,127  7,979  8,025  1,036,266 
12/31/2024 8,115  8,218  8,098  8,101  632,290 
12/30/2024 8,425  8,431  8,046  8,132  1,315,247 
12/26/2024 8,100  8,222  8,075  8,222  1,649,226 
12/25/2024 8,152  8,184  8,101  8,114  324,957 
12/24/2024 8,105  8,199  8,100  8,152  900,568 
12/23/2024 8,094  8,160  7,885  7,969  845,487 
12/19/2024 7,600  7,845  7,593  7,712  1,829,928 
12/18/2024 7,412  7,629  7,300  7,570  3,409,317 
12/17/2024 5,950  7,300  5,920  7,100  6,856,517 
12/16/2024 5,973  5,983  5,860  5,954  835,023 
12/12/2024 6,215  6,310  6,192  6,215  813,708 
12/11/2024 6,265  6,265  6,165  6,175  527,923 
12/10/2024 6,250  6,310  6,249  6,288  1,078,008 
12/09/2024 6,230  6,237  6,088  6,100  934,848 
12/05/2024 6,434  6,440  6,366  6,370  873,696 
12/04/2024 6,320  6,429  6,283  6,401  1,302,187 
12/03/2024 6,040  6,205  6,028  6,200  723,923 
12/02/2024 6,100  6,131  6,064  6,089  694,856 
11/28/2024 6,041  6,041  5,944  5,977  2,118,818 
11/27/2024 6,001  6,071  5,992  6,041  1,208,159 
11/26/2024 6,047  6,061  5,957  5,999  2,153,068 
11/25/2024 6,330  6,355  6,054  6,135  3,284,105 
11/21/2024 6,335  6,380  6,297  6,340  876,415 
11/20/2024 6,290  6,356  6,270  6,320  928,189 
11/19/2024 6,214  6,214  6,130  6,200  981,048 
11/18/2024 6,199  6,213  6,050  6,082  1,219,160 
11/14/2024 6,380  6,412  6,270  6,302  1,086,447 
11/13/2024 6,462  6,517  6,392  6,392  927,046 
11/12/2024 6,527  6,600  6,459  6,459  1,117,143 
11/11/2024 6,506  6,600  6,477  6,526  1,832,203 
11/07/2024 6,550  6,600  6,515  6,536  3,030,602 
11/06/2024 7,040  7,323  6,600  6,650  2,042,945 
11/05/2024 7,005  7,020  6,936  6,952  848,770 
11/04/2024 6,912  7,039  6,902  6,915  726,946 
10/31/2024 6,913  6,917  6,765  6,860  1,173,543 
10/30/2024 6,885  6,897  6,764  6,880  970,286 
10/29/2024 6,824  6,908  6,792  6,880  829,971 
10/28/2024 6,820  6,824  6,705  6,810  767,617 
10/22/2024 6,939  6,939  6,780  6,890  918,006 
10/21/2024 6,809  6,848  6,762  6,829  811,623 
10/15/2024 6,505  6,747  6,472  6,693  801,400 
10/14/2024 6,520  6,548  6,475  6,480  797,537 
10/10/2024 6,693  6,693  6,597  6,629  745,956 
10/09/2024 6,598  6,628  6,500  6,540  392,622 
10/08/2024 6,575  6,575  6,539  6,564  411,266 
10/07/2024 6,613  6,614  6,545  6,600  531,057 
10/01/2024 6,725  6,790  6,592  6,648  1,497,450 
09/30/2024 6,542  6,660  6,510  6,629  1,050,728 
09/26/2024 6,635  6,635  6,635  6,635  2,422,887 
09/25/2024 6,684  6,694  6,585  6,635  704,494 

About Teva Pharmaceutical Stock history

Teva Pharmaceutical investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Teva is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Teva Pharmaceutical will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Teva Pharmaceutical stock prices may prove useful in developing a viable investing in Teva Pharmaceutical
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company was founded in 1901 and is based in Tel Aviv-Yafo, Israel. TEVA PHARMA is traded on Tel Aviv Stock Exchange in Israel.

Teva Pharmaceutical Stock Technical Analysis

Teva Pharmaceutical technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Teva Pharmaceutical technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Teva Pharmaceutical trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Did you try this?

Run Latest Portfolios Now

   

Latest Portfolios

Quick portfolio dashboard that showcases your latest portfolios
All  Next Launch Module

Teva Pharmaceutical Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Teva Pharmaceutical's price direction in advance. Along with the technical and fundamental analysis of Teva Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Teva to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.

Complementary Tools for Teva Stock analysis

When running Teva Pharmaceutical's price analysis, check to measure Teva Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Teva Pharmaceutical is operating at the current time. Most of Teva Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of Teva Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Teva Pharmaceutical's price. Additionally, you may evaluate how the addition of Teva Pharmaceutical to your portfolios can decrease your overall portfolio volatility.
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios